HYFT - Total Utang marang Modal MindWalk Therapeutics

Logo perusahaan publik MindWalk Holdings (HYFT)

The price trend for MindWalk Holdings (HYFT), a progressive developer of AI tools for corporate analytics, shows a metric at 0.50. Demand for such SaaS products is moderately dependent on economic cycles, as companies' drive to optimize costs through automation stabilizes revenues. At the same time, the business relies on a narrow segment of molecule and medical data search, making its financial condition dependent on pharmaceutical grants.

HYFT: Total Utang marang Modal MindWalk Holdings Inc. 05.09.2025 - 01.11.2026
Barang utama MindWalk Therapeutics

MindWalk Holdings (HYFT) competes in the high-tech sector of AI diagnostics and medical digitalization, where scaling requires significant capital expenditures. By analyzing financial leverage through the debt-to-equity ratio, an investor assesses the proportion of borrowed funds within the asset financing structure relative to equity, which determines the business's level of dependence on creditors and the sustainability of its long-term development strategy.

Analisis pesaing MindWalk Holdings

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|ENTX - Rasio Total Utang marang Ekuitas|ABVC BioPharma Inc - Total Utang marang Modal|Koefisien Total Utang marang Modal Cumberland Corp CPIX|Quantum BioPharma Ltd (QNTM) - Utang marang Ekuitas|Rasio Utang marang Ekuitas FGEN|TELO (Telomir Pharmaceuticals, Inc.) - Total Utang marang Modal|Rasio Utang marang Ekuitas RANI (Rani Therapeutics Inc)|Rasio Total Utang marang Ekuitas SNYR (Synergy CHC Corp)|Rasio Total Utang marang Ekuitas rallybio.com RLYB|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|Total Utang marang Modal pulmatrix.com PULM|PTHL - Utang marang Ekuitas|APM: Utang marang Ekuitas|Lyra Therapeutics, Inc (LYRA) - Utang marang Ekuitas|Impact BioMedical, Inc. (IBO) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas TNFA|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|CYTO (altamiratherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Lipella LIPO|OptiNose Corp (OPTN) - Utang marang Modal|PIRS - Utang marang Ekuitas|PROC: Utang marang Ekuitas|PTPI: Total Utang marang Modal|Rasio Utang marang Ekuitas QLI|SLRN (ACELYRIN, Inc.) - Total Utang marang Modal|TFF Pharmaceuticals, Inc (TFFP) - Koefisien Total Utang marang Modal